Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial

{ 'indexed': {'date-parts': [[2024, 4, 16]], 'date-time': '2024-04-16T08:26:53Z', 'timestamp': 1713256013853}, 'reference-count': 40, 'publisher': 'Elsevier BV', 'issue': '4', 'license': [ { 'start': { 'date-parts': [[2020, 10, 1]], 'date-time': '2020-10-01T00:00:00Z', 'timestamp': 1601510400000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}], 'funder': [ { 'DOI': '10.13039/501100004484', 'name': 'Tehran University of Medical Sciences and Health Services', 'doi-asserted-by': 'publisher'}], 'content-domain': { 'domain': [ 'clinicalkey.jp', 'clinicalkey.com', 'clinicalkey.es', 'clinicalkey.com.au', 'clinicalkey.fr', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2020, 10]]}, 'DOI': '10.1016/j.ijantimicag.2020.106143', 'type': 'journal-article', 'created': {'date-parts': [[2020, 8, 25]], 'date-time': '2020-08-25T01:25:25Z', 'timestamp': 1598318725000}, 'page': '106143', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 68, 'title': 'Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised ' 'trial', 'prefix': '10.1016', 'volume': '56', 'author': [ {'given': 'Ehsan', 'family': 'Sekhavati', 'sequence': 'first', 'affiliation': []}, {'given': 'Fatemeh', 'family': 'Jafari', 'sequence': 'additional', 'affiliation': []}, {'given': 'SeyedAhmad', 'family': 'SeyedAlinaghi', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Saeidreza', 'family': 'Jamalimoghadamsiahkali', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sara', 'family': 'Sadr', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mohammad', 'family': 'Tabarestani', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mohammad', 'family': 'Pirhayati', 'sequence': 'additional', 'affiliation': []}, {'given': 'Abolfazl', 'family': 'Zendehdel', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-4610-402X', 'authenticated-orcid': False, 'given': 'Navid', 'family': 'Manafi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mahboubeh', 'family': 'Hajiabdolbaghi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Zahra', 'family': 'Ahmadinejad', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hamid Emadi', 'family': 'Kouchak', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sirous', 'family': 'Jafari', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hosein', 'family': 'Khalili', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mohamadreza', 'family': 'Salehi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Arash', 'family': 'Seifi', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Fereshteh Shahmari', 'family': 'Golestan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fereshteh', 'family': 'Ghiasvand', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.ijantimicag.2020.106143_bib0001', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105924', 'article-title': 'Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ' 'coronavirus disease-2019 (COVID-19): the epidemic and the challenges', 'volume': '55', 'author': 'Lai', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0002', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105948', 'article-title': 'Review of the 2019 novel coronavirus (SARS-CoV-2) based on current ' 'evidence', 'volume': '55', 'author': 'Wang', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0003', 'doi-asserted-by': 'crossref', 'first-page': 'e00820', 'DOI': '10.1016/j.idcr.2020.e00820', 'article-title': 'Isolated severe thrombocytopenia in a patient with COVID-19: a case ' 'report', 'volume': '21', 'author': 'Sadr', 'year': '2020', 'journal-title': 'IDCases'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0004', 'doi-asserted-by': 'crossref', 'first-page': '35', 'DOI': '10.1016/j.clinimag.2020.05.013', 'article-title': 'Extrapulmonary manifestations of COVID-19: radiologic and clinical ' 'overview', 'volume': '66', 'author': 'Behzad', 'year': '2020', 'journal-title': 'Clin Imaging'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0005', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.jcv.2020.104371', 'article-title': 'Prevalence and severity of corona virus disease 2019 (COVID-19): a ' 'systematic review and meta-analysis', 'volume': '127', 'author': 'Hu', 'year': '2020', 'journal-title': 'J Clin Virol'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0006', 'doi-asserted-by': 'crossref', 'first-page': '279', 'DOI': '10.1016/j.jcrc.2020.03.005', 'article-title': 'A systematic review on the efficacy and safety of chloroquine for the ' 'treatment of COVID-19', 'volume': '57', 'author': 'Cortegiani', 'year': '2020', 'journal-title': 'J Crit Care'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0007', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105923', 'article-title': 'Chloroquine for the 2019 novel coronavirus SARS-CoV-2', 'volume': '55', 'author': 'Colson', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0008', 'doi-asserted-by': 'crossref', 'first-page': '67', 'DOI': '10.1016/S1473-3099(06)70361-9', 'article-title': 'New insights into the antiviral effects of chloroquine', 'volume': '6', 'author': 'Savarino', 'year': '2006', 'journal-title': 'Lancet Infect Dis'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0009', 'doi-asserted-by': 'crossref', 'first-page': '1377', 'DOI': '10.1016/S0161-6420(02)01168-5', 'article-title': 'Recommendations on screening for chloroquine and hydroxychloroquine ' 'retinopathy: a report by the American Academy of Ophthalmology', 'volume': '109', 'author': 'Marmor', 'year': '2002', 'journal-title': 'Ophthalmology'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0010', 'doi-asserted-by': 'crossref', 'first-page': '732', 'DOI': '10.1093/cid/ciaa237', 'article-title': 'In vitro antiviral activity and projection of optimized dosing design ' 'of hydroxychloroquine for the treatment of severe acute respiratory ' 'syndrome coronavirus 2 (SARS-CoV-2)', 'volume': '71', 'author': 'Yao', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0011', 'doi-asserted-by': 'crossref', 'first-page': '5891', 'DOI': '10.21873/anticanres.13793', 'article-title': 'Lopinavir–ritonavir combination induces endoplasmic reticulum stress ' 'and kills urological cancer cells', 'volume': '39', 'author': 'Okubo', 'year': '2019', 'journal-title': 'Anticancer Res'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0012', 'doi-asserted-by': 'crossref', 'first-page': '81', 'DOI': '10.1186/s13063-017-2427-0', 'article-title': 'Treatment of Middle East respiratory syndrome with a combination of ' 'lopinavir–ritonavir and interferon-β1b (MIRACLE trial): study protocol ' 'for a randomized controlled trial', 'volume': '19', 'author': 'Arabi', 'year': '2018', 'journal-title': 'Trials'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0013', 'doi-asserted-by': 'crossref', 'first-page': '69', 'DOI': '10.1016/j.jcv.2004.03.003', 'article-title': 'In vitro susceptibility of 10 clinical isolates of SARS coronavirus to ' 'selected antiviral compounds', 'volume': '31', 'author': 'Chen', 'year': '2004', 'journal-title': 'J Clin Virol'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0014', 'doi-asserted-by': 'crossref', 'first-page': '252', 'DOI': '10.1136/thorax.2003.012658', 'article-title': 'Role of lopinavir/ritonavir in the treatment of SARS: initial ' 'virological and clinical findings', 'volume': '59', 'author': 'Chu', 'year': '2004', 'journal-title': 'Thorax'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0015', 'doi-asserted-by': 'crossref', 'first-page': '10012', 'DOI': '10.1073/pnas.0403596101', 'article-title': 'Small molecules targeting severe acute respiratory syndrome human ' 'coronavirus', 'volume': '101', 'author': 'Wu', 'year': '2004', 'journal-title': 'Proc Natl Acad Sci U S A'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0016', 'doi-asserted-by': 'crossref', 'first-page': '2034', 'DOI': '10.1001/jama.2015.13896', 'article-title': 'Early administration of azithromycin and prevention of severe lower ' 'respiratory tract illnesses in preschool children with a history of ' 'such illnesses: a randomized clinical trial', 'volume': '314', 'author': 'Bacharier', 'year': '2015', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0017', 'doi-asserted-by': 'crossref', 'first-page': '6', 'DOI': '10.4172/1948-5964.1000173', 'article-title': 'Azithromycin inhibits the replication of Zika virus', 'volume': '10', 'author': 'Bosseboeuf', 'year': '2018', 'journal-title': 'J Antivir Antiretrovir'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0018', 'article-title': 'Energetics based modeling of hydroxychloroquine and azithromycin ' 'binding to the SARS-CoV-2 spike (S) protein–ACE2 complex', 'author': 'Sandeep', 'year': '2020', 'journal-title': 'ChemRxiv'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0019', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.cell.2020.04.004', 'article-title': 'Inhibition of SARS-CoV-2 infections in engineered human tissues using ' 'clinical-grade soluble human ACE2', 'volume': '181', 'author': 'Monteil', 'year': '2020', 'journal-title': 'Cell'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0020', 'series-title': "Sermo's COVID-19 real time barometer study", 'year': '2020'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0021', 'doi-asserted-by': 'crossref', 'first-page': '808', 'DOI': '10.1038/s41591-020-0888-2', 'article-title': 'The QT interval in patients with COVID-19 treated with ' 'hydroxychloroquine and azithromycin', 'volume': '26', 'author': 'Chorin', 'year': '2020', 'journal-title': 'Nat Med'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0022', 'doi-asserted-by': 'crossref', 'first-page': '286', 'DOI': '10.1097/RHU.0b013e31829d5e50', 'article-title': 'Suspected hydroxychloroquine-associated QT-interval prolongation in a ' 'patient with systemic lupus erythematosus', 'volume': '19', 'author': 'Morgan', 'year': '2013', 'journal-title': 'J Clin Rheumatol'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0023', 'article-title': 'Ventricular arrhythmia risk due to hydroxychloroquine–azithromycin ' 'treatment for COVID-19', 'author': 'Simpson', 'year': '2020', 'journal-title': 'Cardiology Magazine'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0024', 'doi-asserted-by': 'crossref', 'first-page': '315', 'DOI': '10.4330/wjc.v7.i6.315', 'article-title': 'Nomenclature, categorization and usage of formulae to adjust QT ' 'interval for heart rate', 'volume': '7', 'author': 'Rabkin', 'year': '2015', 'journal-title': 'World J Cardiol'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0025', 'first-page': '1824', 'article-title': 'Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a ' 'review', 'volume': '323', 'author': 'Sanders', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0026', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.nmni.2020.100684', 'article-title': 'Potential use of hydroxychloroquine, ivermectin and azithromycin drugs ' 'in fighting COVID-19: trends, scope and relevance', 'volume': '35', 'author': 'Choudhary', 'year': '2020', 'journal-title': 'New Microbes New Infect'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0027', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105949', 'article-title': 'Hydroxychloroquine and azithromycin as a treatment of COVID-19: results ' 'of an open-label non-randomized clinical trial', 'volume': '56', 'author': 'Gautret', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0028', 'doi-asserted-by': 'crossref', 'first-page': '436', 'DOI': '10.1016/j.jmii.2020.03.034', 'article-title': 'Treatment options for COVID-19: the reality and challenges', 'volume': '53', 'author': 'Jean', 'year': '2020', 'journal-title': 'J Microbiol Immunol Infect'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0029', 'article-title': 'Hydroxychloroquine and azithromycin as a treatment of COVID-19', 'volume': '23', 'author': 'Fanin', 'year': '2020', 'journal-title': 'Intern Emerg Med'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0030', 'article-title': 'A Bayesian reanalysis of the effects of hydroxychloroquine and ' 'azithromycin on viral carriage in patients with COVID-19', 'author': 'Hulme', 'year': '2020', 'journal-title': 'MedRxiv'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0031', 'series-title': 'Comments on the hydroxychloroquine/azithromycin study and lessons for ' 'future clinical trials of COVID-19 treatments', 'author': 'Negida', 'year': '2020'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0032', 'article-title': 'Statistical review of hydroxychloroquine and azithromycin as a ' 'treatment of COVID-19: results of an open-label nonrandomized clinical ' 'trial', 'author': 'Dahly', 'year': '2020', 'journal-title': 'Preprint posted online'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0033', 'doi-asserted-by': 'crossref', 'first-page': '384', 'DOI': '10.1016/j.medmal.2020.03.006', 'article-title': 'No evidence of rapid antiviral clearance or clinical benefit with the ' 'combination of hydroxychloroquine and azithromycin in patients with ' 'severe COVID-19 infection', 'volume': '50', 'author': 'Molina', 'year': '2020', 'journal-title': 'Med Mal Infect'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0034', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.tmaid.2020.101738', 'article-title': 'Early treatment of COVID-19 patients with hydroxychloroquine and ' 'azithromycin: a retrospective analysis of 1061 cases in Marseille, ' 'France', 'volume': '35', 'author': 'Million', 'year': '2020', 'journal-title': 'Travel Med Infect Dis'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0035', 'doi-asserted-by': 'crossref', 'DOI': '10.1056/NEJMoa2019014', 'article-title': 'Hydroxychloroquine with or without azithromycin in mild-to-moderate ' 'COVID-19', 'author': 'Cavalcanti', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0036', 'doi-asserted-by': 'crossref', 'first-page': '2493', 'DOI': '10.1001/jama.2020.8630', 'article-title': 'Association of treatment with hydroxychloroquine or azithromycin with ' 'in-hospital mortality in patients with COVID-19 in New York State', 'volume': '323', 'author': 'Rosenberg', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0037', 'doi-asserted-by': 'crossref', 'first-page': '396', 'DOI': '10.1016/j.ijid.2020.06.099', 'article-title': 'Treatment with hydroxychloroquine, azithromycin, and combination in ' 'patients hospitalized with COVID-19', 'volume': '97', 'author': 'Arshad', 'year': '2020', 'journal-title': 'Int J Infect Dis'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0038', 'doi-asserted-by': 'crossref', 'first-page': '244', 'DOI': '10.1016/j.hrcr.2020.03.016', 'article-title': 'An algorithm for managing QT prolongation in coronavirus disease 2019 ' '(COVID-19) patients treated with either chloroquine or ' 'hydroxychloroquine in conjunction with azithromycin: possible benefits ' 'of intravenous lidocaine', 'volume': '6', 'author': 'Mitra', 'year': '2020', 'journal-title': 'HeartRhythm Case Rep'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0039', 'doi-asserted-by': 'crossref', 'first-page': 'E450', 'DOI': '10.1503/cmaj.200528', 'article-title': 'Safety considerations with chloroquine, hydroxychloroquine and ' 'azithromycin in the management of SARS-CoV-2 infection', 'volume': '192', 'author': 'Juurlink', 'year': '2020', 'journal-title': 'Can Med Assoc J'}, { 'key': '10.1016/j.ijantimicag.2020.106143_bib0040', 'article-title': 'Safety of hydroxychloroquine, alone and in combination with ' 'azithromycin, in light of rapid wide-spread use for COVID-19: a ' 'multinational, network cohort and self-controlled case series study', 'author': 'Lane', 'year': '2020', 'journal-title': 'MedRxiv'}], 'container-title': 'International Journal of Antimicrobial Agents', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0924857920303411?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0924857920303411?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2021, 1, 14]], 'date-time': '2021-01-14T23:44:02Z', 'timestamp': 1610667842000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0924857920303411'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 10]]}, 'references-count': 40, 'journal-issue': {'issue': '4', 'published-print': {'date-parts': [[2020, 10]]}}, 'alternative-id': ['S0924857920303411'], 'URL': 'http://dx.doi.org/10.1016/j.ijantimicag.2020.106143', 'relation': {}, 'ISSN': ['0924-8579'], 'subject': ['Pharmacology (medical)', 'Infectious Diseases', 'Microbiology (medical)', 'General Medicine'], 'container-title-short': 'International Journal of Antimicrobial Agents', 'published': {'date-parts': [[2020, 10]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Safety and effectiveness of azithromycin in patients with COVID-19: An ' 'open-label randomised trial', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'International Journal of Antimicrobial Agents', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.ijantimicag.2020.106143', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2020 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. ' 'All rights reserved.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': '106143'}